Commerce Opens Path for Drugmakers to Cut Section 232 Pharma Tariffs

Posted 5/11/26

The Commerce Department’s Bureau of Industry and Security laid out procedures for pharmaceutical companies to seek company-specific onshoring agreements that could sharply reduce new Section 232 tariffs on patented drugs and related ingredients.

This item is available in full to subscribers.

Please log in to continue

Log in